Valeant Pharmaceuticals International Inc. (TSE:VRX) received a joint takeover offer from Japan's Takeda Pharmaceutical Co Ltd and TPG Capital Management LP this spring that the Canadian drugmaker rejected, according to a source familiar with the matter.
LAVAL, Que. — Embattled drug company Valeant Pharmaceuticals International Inc. has named Joseph Papa as its new chairman and chief executive.
The company says Papa, who was chairman and CEO of drug company Perrigo in the U.S., is expected to join Valeant early next month.
